12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Other News

InterMune, Shionogi pulmonary news

Shionogi filed suit in the U.S. District Court for the Northern District of California alleging that InterMune breached an amended 2004 deal regarding idiopathic pulmonary fibrosis (IPF) drug Esbriet pirfenidone. Shionogi alleges that InterMune failed to pay royalties to Shionogi on sales of Esbriet in the EU as required under the deal. According to court documents, the companies entered into...

Read the full 288 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >